I can’t believe its my 75th trip out to Washington DC since Woody died in August 2003. As I was preparing for this trip, I was reflecting on what little progress has been made in […]
2016 started out with the tragic reminder of how fragile life is. Last week one of my good friends – Karen Langhart took her life. She was just 56 years old. I will never forget […]
I (K.W.) have been thinking a lot lately about mental health. It seems every where you turn, there’s something about “mental health” in the headlines. Whether its another shooting, the high profile suicide of Robin […]
One of the tasks I (LT) perform annually as a progressive activist is to write lengthy holiday cards of solidarity and encouragement to wrongfully incarcerated sex offenders identified by a small almost all-volunteer organization, the […]
This is sad sad news. The Canadian Women’s Health Network (CWHN), one of the pillars of the women’s health movement in North America, has announced that it is suspending activities due to a lack of funds […]
The FDA wants to know how the process for soliciting patients for the “patient focused drug development” meetings is going. That phrase “Patient focused drug development” may ring a bell with you, but if not, […]
In mid October, the FDA convened a special meeting of drug safety and psycho-pharmacology experts to look at whether or not the smoking cessation drug Chantix needed to continue to carry a black box warning. […]
Here’s the third installment of the saga about PR tactics on the “female sexual dysfunction” front as we get closer to the October 27/28 meeting on FSD and Patient-focused drug development. I (L.T.) first wrote […]
This summer we saw the ultimate game of truth and dare play out over social media with the ALS Ice Bucket Challenge. All over the world ordinary people as well as celebrities, billionaires, professional athletes, police […]
Placebo response levels in many drug trials are high, especially with therapeutic areas that rely on patient-reported outcome measures. I (LT) recently read a very thoughtful paper by sexologist Andrea Bradford called “Listening to placebo […]
Recently I (KW) was reminded again that not all “patient” voices are treated equally. All one has to do is look at two Congressional hearings held in Washington DC last month to see how different […]
I (L.T.) wrote here in April about the behind-the-scenes tactics of Sprout Pharmaceuticals in pre-approval maneuvering on behalf of its drug for women’s low sexual desire, flibanserin. Well, wouldn’t you k now that just as the […]
Colorado has recently signed the first “Right to Try” law allowing patients with terminal diagnoses who are out of medical options to apply directly to companies to try drugs that are in development but which have […]
Its hard to believe that it has been almost ten years since black box warnings were added to antidepressants. These warnings came 13 years after the FDA first held hearings on link between Prozac and suicide […]
Although I (L.T.) have thought and written for years about medicalization (especially the medicalization of sex), the application of this concept to issues of global health is new to me. Jocalyn Clark, a PhD public […]
Earlier this year, the FDA revisited its policies on distributing reprints of medical and scientific journal publications in its revised draft guidance entitled, “Distributing Scientific and Medical Publications on Unapproved New Uses–Recommended Practices” . If it […]
Escalating calls for a “patient revolution” are pouring in from the blogs and books of doctors, researchers, patients, activists, and all sorts of policy people. The movement is not all new, however. In “Towards the […]
I (LT) have learned about the machinations of SELLING SICKNESS largely through decades of work as a sexologist examining and trying to limit the medicalization of sexuality. Flibanserin is a serotonergic antidepressant proposed to help […]
Investigative journalism is essential to the project of SELLING SICKNESS as we seek to understand disease-mongering and promote healthcare reform. PROPUBLICA, an online newsroom that produces journalism “in the public interest,” is becoming an important partner […]
Are you tired of television ads for prescription drugs that warn of nausea, insomnia, diarrhea and suicidal thoughts? Well, I (KW) am and I’m not alone. In my opinion, it’s crazy that direct-to-consumer marketing is […]
The charmingly named China, Maine, is a small American town of about 5000 souls in the middle of a small northern state. None of us in the healthcare reform community would ever have heard of […]
Breathe in, 2, 3, 4. Hold it. Breathe out, 2, 3, 4. Generalize to the world! Over the past 3 decades, a spreading “Slow Movement” has been challenging the prevailing social tendency to cram as […]
The Choosing Wisely project, begun only in 2011, is really picking up speed. Dozens of medical specialty organizations have now contributed their lists of five interventions that should be questioned (e.g., do you really need pre-procedure […]
The number of people diagnosed with ADHD continues to skyrocket. It can’t be explained on the basis of genetics or biology. Rather it seems this increase in diagnosis is simply the result of Big Pharma […]
As I (KW) reflect back on 2013, I am proud of the contributions Selling Sickness has made to the rapidly growing new social health reform movement. This was a breakout year for multidisciplinary conferences on […]
Kim and I (LT) attended the 2nd Lown Conference “From Avoidable Care to Right Care” in Boston last week. This event marked the end of a high water mark year for multidisciplinary conferences on overdiagnosis […]
It’s not just women’s problem anymore. As a feminist, I (LT) have watched for decades the worrisome news about the safety of reproductive hormones for menopause symptoms, pre-menstrual complaints, and oral contraceptives. The history of the use and marketing of […]
Dr. Leana Sheryle Wen is all of 30 years old, but she is a speed demon of accomplishment and, if I may say, a beacon of light in our new selling sickness movement. Her two […]
KW and LT presented a live-streamed “National Grand Rounds” on October 19, 2013 at the annual conference of the National Physicians Alliance in Washington titled Challenging the Selling of Sickness: A New Partnership Movement of Professionals and […]
I (KW) have been thinking lately about the importance of personal stories/narratives in our partnership work at Selling Sickness. It fits with one of the principles at the core of our partnership model — mutual […]
Penn State administrators recently introduced a new health plan requiring nonunion employees (faculty, clerical staff) to visit their doctors for an annual checkup, undergo several biometric tests (fasting lipid profile and fasting glucose (finger stick), […]
One of my favorite writers, Adam Gopnik of The New Yorker, this week takes on the excesses of neurobiological explanations in an essay called “Mindless.” He describes how neuroscience often merely restates the obvious in […]
I (KW) have personally never been a fan of celebrity endorsements used by marketers to create brand awareness and association to increase sales. It’s one thing to use celebrities and stylists to create a relationship […]
I (LT) have an international houseguest and am all stressed out about getting the WiFi working and finding three pronged plugs. It’s stressful to guess about the right stuff for breakfast and I’m already stressing […]
Menopause is back on the front burner for Big Pharma. A new campaign with full-age ads in the NYTimes promotes Novo-Nordisk’s hormonal products for hot flashes and atrophic vaginas. Lots of interactive online checklists to print out […]
The Sunday Business Section of the NY Times recently featured a long story about the work of Peter Doshi, one of the exciting speakers at our Selling Sickness conference. You can view his talk on […]
The Business of Technology (BIT) staff at the New York Times produced a special section a few days ago focusing on a half-dozen areas of growth involving “Big Data.” “The story is the same in […]
When you post something on FB, you are both a producer and a consumer. This is the heart of the notion of “prosumption,” a term introduced to me (LT) by Deborah Lupton, the Australian sociologist, […]
This week the British Medical Journal published our editorial calling for a new social health movement to challenge the “Selling of Sickness.” The time has come for a movement using a partnership model that combines […]
Our Call to Action went live on April 22, 2013, and as of this moment, 2 weeks later, we have 278 individual endorsers from all over the world, with more signing every day. Our editorial […]
A new study just published in the Journal of General Internal Medicine involving Canadian, US and French physicians shows that the majority of family doctors receive little or no information about a drug’s harmful side […]
Following the FDA’s 2010 rejection of flibanserin, the ineffective and possibly dangerous CNS drug proposed for “female sexual dysfunction (FSD)” and the 2nd FSD drug to fail at the FDA, the International Society for the […]
Next month is the long-awaited debut of the fifth edition of the Diagnostic and Statistical Manual of the American Psychiatric Association, the DSM-V (now known as DSM-5, a change which is odd since even football […]
Earlier this week I (KW) was invited to Washington to attend “Using Comparative Effectiveness Research to Improve Health Care” sponsored by Consumer Reports and National Research Center for Women and Families. It brought together over […]
I (LT) just gave a workshop about “Selling Sickness, 2013” at the annual meeting of the Association for Women in Psychology (AWP), held this weekend in sunny Salt Lake City, Utah. A lively group turned […]
It seems self-serving to say that the Selling Sickness conference was a blockbuster, but it was. Attended by around 225 advocates, academics, journalists, health care providers, legislators, students, lawyers, librarians, writers From Russia, Finland, Germany, […]
OK, now, don’t get upset. The lymphomaniac joke is from a cancer patients’ website and this blog is about the uses of humor in activism. So take a deep breath and unbutton your mind a […]
Boldly challenging disease-mongering (DTCA, PhRMA, FDA, accountability, clinical guidelines, transparency, RCT, validity, misleading marketing, etc.) will inevitably produce angry and dismissive reactions and rebukes from pharmaceutical companies and others with vested interests in selling sickness. […]
Anthropologist Joe Dumit has written one of the most important and radical (getting to the root) books about health, marketing, medical research, and the pharmaceutical industry in recent decades, Drugs for Life: How pharmaceutical companies […]
I (K.W) can’t believe that it’s been 10 years since my funny young husband, Woody, died as a result of Zoloft-induced suicide. It’s been a long journey learning to live with a new “normal.” Only […]
From the outset of our planning, we wanted our conference to be part of a progressive and activist health movement. The previous Selling Sickness conferences (Australia, 2006; Amsterdam, 2010) brought together scholars who brilliantly unpacked […]
A public petition went up on alltrials.net today asking for support (from anybody) for the demand to register all clinical trials for all medical treatments, past and present, and to make sure that the full […]
It’s hard to believe that our “Selling Sickness 2013: People Before Profits” conference is less than two months away. It seems like just yesterday that I (K.W.) attended the 2010 Selling Sickness conference in Amsterdam. […]
Iona Heath, past president of the UK Royal College of General Practictitioners and an early supporter and advisor for our Selling Sickness conference, wrote a column in the 31 October 2009 BMJ titled: The Perversion […]
Leonore flew out to Minneapolis this past weekend so she and Kim could sit at a big table with all the bits and pieces of program and finally put it all together. We’ve been speaking […]
This title comes from a 2007 editorial by Kurt Stange in the Annals of Family Medicine but the heartfelt sentiment comes from many, many reformers working in the field of healthcare. Read Stange’s review of the biases […]
Earlier this month I (K.W.) attended the Consumers Union’s Safe Patient Project summit at Consumer Reports headquarters in Yonkers, NY. Over 31 talented advocates from 17 states came to learn, network and share ideas about […]
I got really excited today when Susan Davis, a Melbourne physician who has conducted umpteen clinical trials trying to find a testosterone treatment for women with sexual complaints that will work better than placebo (keep […]
Overtreatment, overmarketing, conflicts-of-interest and all the trappings of disease-mongering pertain not just to medical treatments, education, publishing, screening and drugs, but, increasingly, to medical devices, both the kind that are used IN the body and […]
It’s been a rough week in the Big Apple. I’ve lived in New York City most of my life, through hurricanes and blizzards, terrorist attacks and tourist invasions, not to mention regular teacher/sanitation/transportation/newspaper union strikes, […]
A pillar of future professional and lay health education that incorporates disease-mongering awareness must deal with how to discontinue drugs when they are no longer wanted (ineffective, causing adverse reactions, interacting deleteriously with other drugs), […]
I (K.W.) recently went to the gynecologist for my annual exam. The office gave me the usual paperwork, but this time I noticed something new — a checklist about my mental health. It asked, “Over […]
The meningitis outbreak caused by contaminated medicine from a Massachusetts compounding pharmacy has become a full-fledged health scandal with its inevitable elements: avoidable deaths, journalistic outrage, competing investigations, finger-pointing, newly discovered conflicts of interest/incompetence/corruption, resignations, […]
“Valium’s Contribution to the New Normal,” an opinion piece in the New York Times this week by longtime health writer Robin Marantz Henig, reviewed the public’s embrace of new expectations for mental equilibrium following the […]
Everyone seems to be talking about “patients” these days. It’s the word du jour. The drug industry says patients are their reason for being in business. National disease advocacy groups represent the voices of their […]
It’s obvious to many how Big Pharma contributes to overtreatment, overdiagnosis, misleading marketing (i.e., Disease-Mongering). But what about Big Biotech? Case in point: Direct-to-Consumer Genetic Testing. How about sex selection to achieve a “balanced family“? Have […]
Why am I not surprised to see that pharma is increasingly using Pinterest, the social photo-sharing website to reach millions of monthly online visitors. Drug companies are marketers. Plain and simple. They are using all […]
Another new study showing that organically raised food is NOT more healthy or nutritious has predictably caused a firestorm of objection. Marion Nestle, my favorite evidence-based food scientist, blogs about this brilliantly from New York. […]
The New York Times health columnist, Tara Parker-Pope, is focusing on overtreatment in her contributions to “The Agenda,” a blog following the major issues of the election: Economy, World, Health, Security, Planet (I guess that’s […]
What is the Selling Sickness 2013 logo saying? We thought long and hard about how to communicate our goal for the spirit of this conference, not just our antipathy towards disease mongering. Pills or other […]
Every week seems to bring important news about overdiagnosis, either in terms of medical guidelines, scientific papers, investigative revelations, or whistleblower disclosure. The big news this week (so far!) has to do with the “management” […]
This is Leonore Tiefer starting off our conference blog from New York. There are already many wonderful blogs and books and videos about disease-mongering – overdiagnosis, overtreatment, overmarketing, overmedicalization, conflicts of interest – and we […]
Susbscribe to our awesome Blog Feed or Comments Feed